Bank of New York Mellon’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bank of New York Mellon’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-545,069	Closed	-$1.38M	–	4388
2023 Q4	$1.38M	Buy	545,069 +26,431	+5%	+$61.6K	﹤0.01%	3018
2023 Q3	$1.24M	Sell	518,638 -1,948	-0.4%	-$4.31K	﹤0.01%	3046
2023 Q2	$1.2M	Sell	520,586 -26,099	-5%	-$73.7K	﹤0.01%	3099
2023 Q1	$1.39M	Buy	546,685 +5,879	+1%	+$16.8K	﹤0.01%	2991
2022 Q4	$1.36M	Sell	540,806 -10,391	-2%	-$29K	﹤0.01%	3046
2022 Q3	$1.6M	Sell	551,197 -4,810	-0.9%	-$20.2K	﹤0.01%	2974
2022 Q2	$2.51M	Buy	556,007 +425,924	+327%	+$2.53M	﹤0.01%	2705
2022 Q1	$1.04M	Buy	130,083 +1,283	+1%	+$11.3K	﹤0.01%	3284
2021 Q4	$1.5M	Buy	128,800 +74,214	+136%	+$889K	﹤0.01%	3153
2021 Q3	$676K	Buy	+54,586	New	+$616K	﹤0.01%	3633

Bank of New York Mellon's SLGC Position: Q1 2024 in Review

Bank of New York Mellon sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 545,069 shares — an estimated $1.38M sold.

Bank of New York Mellon first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $2.51M in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Bank of New York Mellon reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Bank of New York Mellon sold 545,069 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $1.38M.
Bank of New York Mellon first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
Bank of New York Mellon's SomaLogic, Inc. Class A Common Stock position peaked at $2.51M in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.